Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Editor’s Choice
What is the prospect of a safe and effective dengue vaccine for travellers?
Anna P Durbin, MD, Duane J Gubler, ScD
Journal of Travel Medicine, Volume 26, Issue 6, 2019, tay153, https://doi.org/10.1093/jtm/tay153
Dengue affects hundreds of millions of persons each year and is a risk for travellers to dengue-endemic regions. The first licensed dengue vaccine is approved for use only in persons who are known to have had previous dengue infection, limiting its potential for use in travellers. Two other dengue vaccines are currently in Phase 3 clinical trials, with preliminary efficacy results expected soon. These vaccines differ from the currently licensed vaccine and, should they demonstrate efficacy, may offer the possibility of a dengue vaccine for travellers.

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Addressing vaccine hesitancy in travellers: The CARD™ System
Anna Taddio, PhD, Noni MacDonald, MD
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz056, https://doi.org/10.1093/jtm/taz056
Current vaccination programs do not fully incorporate client-centred care in the delivery of vaccinations; hence, do not address vaccination hesitancy. This article provides a summary of a novel client-centred approach to vaccinations to improve the vaccination experience and promote vaccination.

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Perspectives
Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?
Wesley de Jong, MD, Rob A de Man, MD PhD, Virgil A S H Dalm, MD PhD, Chantal B E M Reusken, PhD, Marco Goeijenbier, MD PhD …
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz015, https://doi.org/10.1093/jtm/taz015
Improved quality of life in immunocompromised patients opens travel opportunities, but administering the yellow fever (YF) vaccine is often contraindicated. We advocate re-evaluating this position for immunocompromised patients who travel frequently or who are migrating to regions in which YF is endemic.

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Fractional-dose yellow fever vaccination: an expert review
Anna H E Roukens, MD, PhD, Leo G Visser, MD, PhD
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz024, https://doi.org/10.1093/jtm/taz024

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Seroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional study
Cornelia Staehelin, MD, MIH, Afona Chernet, PhD, Véronique Sydow, MD, Rein J Piso, MD, Franziska Suter-Riniker, PhD …

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Rapid Communication
Measles and the 2019 Hajj: the risk of magnifying the global measles surge
Ziad A Memish, MD, FRCPC, FRCPE, FRCPL, FACP, FFPH, Anas A Khan, MD, Shahul Ebrahim, MD, MSc, PhD
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz041, https://doi.org/10.1093/jtm/taz041
The projected linear increases in Muslim pilgrims for Hajj and Umra to Saudi Arabia from current 7 million to 30 million by 2030 will increase the density of pilgrims and the potential for infectious disease transmission. Because pilgrims originate from over 180 countries, the Hajj and Umrah pilgrimage can further compound the ongoing measles outbreaks. Vaccine hesitancy among Muslim populations should receive special attention in addition to general measles control efforts.

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

The rise in travel-associated measles infections—GeoSentinel, 2015–2019
Kristina M Angelo, Michael Libman, Philippe Gautret, Elizabeth Barnett, Martin P Grobusch …
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz046, https://doi.org/10.1093/jtm/taz046
The global threat of measles in recent years affects international travelers, and is acquired in both endemic and outbreak settings. The number of measles cases reported to GeoSentinel has risen each year since 2015 and demonstrates a high median age, short travel duration, and low measles

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Yellow fever and Hajj 2019: from airline introduction of mosquitoes to expanding geography of transmission and vaccination challenges
Shahul H Ebrahim, MD, Ziad A Memish, MD
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz051, https://doi.org/10.1093/jtm/taz051
Yellow fever epidemiology is changing with large-scale epidemics in Africa, increased risk of urban outbreaks in Latin America, and spread to Asia. Therefore, in addition to the changing epidemiology, mosquito resurgence, and urbanization of yellow fever, the Hajj 2019 presents another challenge to the well-structured global strategy for YF Control.

Journal of Travel Medicine
Volume 26, Issue 6, 2019
https://academic.oup.com/jtm/issue/26/6

Measles and the 2019 Hajj: risk of international transmission
Sakshi Shetty, Maya Murmann, Ashleigh R Tuite, Alexander G Watts, Isaac Bogoch …
Journal of Travel Medicine, Volume 26, Issue 6, 2019, taz058, https://doi.org/10.1093/jtm/taz058
The current global increase in measles cases is associated with a small but non-negligible risk of an infected pilgrim arriving at the 2019 Hajj. Since even a single imported case can cause an outbreak in vulnerable populations, Saudi Arabia and countries with returning pilgrims should be alert for measles cases.

Lancet Respiratory Medicine
Sep 2019 Volume 7 Number 9 p721-826, e26-e28
http://www.thelancet.com/journals/lanres/issue/current

Series
Tuberculosis 2019
Insights and challenges in tuberculosis vaccine development
Helen McShane
Summary
Tuberculosis kills more people than any other pathogen and the need for a universally effective vaccine has never been greater. An effective vaccine will be a key tool in achieving the targets set by WHO in the End TB Strategy. Tuberculosis vaccine development is difficult and slow. Substantial progress has been made in research and development of tuberculosis vaccines in the past 20 years, and two clinical trial results from 2018 provide reason for optimism. However, many challenges to the successful licensure and deployment of an effective tuberculosis vaccine remain. The development of new tools for vaccine evaluation might facilitate these processes, and continued collaborative working and sustained funding will be essential.

Lancet Respiratory Medicine
Sep 2019 Volume 7 Number 9 p721-826, e26-e28
http://www.thelancet.com/journals/lanres/issue/current

Commission Update
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
Keertan Dheda, Tawanda Gumbo,Gary Maartens, Kelly E Dooley, Megan Murray, Jennifer Furin,
Edward A Nardell, Robin M Warren, on behalf of The Lancet Respiratory Medicine drug-resistant tuberculosis Commission group
Summary
The Lancet Respiratory Medicine Commission on drug-resistant tuberculosis was published in 2017, which comprehensively reviewed and provided recommendations on various aspects of the disease. Several key new developments regarding drug-resistant tuberculosis are outlined in this Commission Update. The WHO guidelines on treating drug-resistant tuberculosis were updated in 2019 with a reclassification of second line anti-tuberculosis drugs. An injection-free MDR tuberculosis treatment regimen is now recommended. Over the past 3 years, advances in treatment include the recognition of the safety and mortality benefit of bedaquiline, the finding that the 9–11 month injectable-based ‘Bangladesh’ regimen was non-inferior to longer regimens, and promising interim results of a novel 6 month 3-drug regimen (bedaquiline, pretomanid, and linezolid). Studies of explanted lungs from patients with drug-resistant tuberculosis have shown substantial drug-specific gradients across pulmonary cavities, suggesting that alternative dosing and drug delivery strategies are needed to reduce functional monotherapy at the site of disease. Several controversies are discussed including the optimal route of drug administration, optimal number of drugs constituting a regimen, selection of individual drugs for a regimen, duration of the regimen, and minimal desirable standards of antibiotic stewardship. Newer rapid nucleic acid amplification test platforms, including point-of-care systems that facilitate active case-finding, are discussed. The rapid diagnosis of resistance to other drugs, (notably fluoroquinolones), and detection of resistance by targeted or whole genome sequencing will probably change the diagnostic landscape in the near future.

Nature Genetics
Volume 51 Issue 9, September 2019
https://www.nature.com/ng/volumes/51/issues/9

Editorial | 02 September 2019
Mendel for the modern era
The genome of the model genetic organism Pisum sativum, or pea plant, links nineteenth-century genetics to twenty-first-century genomics, serving as a symbol of how far the genetics field has developed and how greatly technologies have advanced. Almost every student’s introduction to genetics currently involves learning Mendel’s laws; we envision that genomics and genome sequencing will become just as foundational in the education of future geneticists.

Nature Genetics
Volume 51 Issue 9, September 2019
https://www.nature.com/ng/volumes/51/issues/9

Article | 02 September 2019 | Open Access
A reference genome for pea provides insight into legume genome evolution
The first annotated chromosome-level reference genome assembly for pea, Gregor Mendel’s original genetic model, provides insights into legume genome evolution and the molecular basis of agricultural traits for pea improvement.
Jonathan Kreplak, Mohammed-Amin Madoui[…] & Judith Burstin

New England Journal of Medicine
September 5, 2019 Vol. 381 No. 10
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Toppling the Ethical Balance — Health Care Refusal and the Trump Administration
E. Sepper
A new rule from the U.S. Department of Health and Human Services creates a wide-ranging right to refuse to provide health care services. If it goes into effect, patient health and professional practice are likely to suffer.

Pediatrics
September 2019, VOLUME 144 / ISSUE 3
https://pediatrics.aappublications.org/content/144/3?current-issue=y

Articles
Early Childhood Vaccination Status of Preterm Infants
Annika M. Hofstetter, Elizabeth N. Jacobson, M. Patricia deHart, Janet A. Englund
Pediatrics Sep 2019, 144 (3) e20183520; DOI: 10.1542/peds.2018-3520
In this retrospective study, we used EHR and immunization information system data to compare early childhood vaccination of preterm and term/post term infants born between 2008 and 2013.

Pediatrics
September 2019, VOLUME 144 / ISSUE 3
https://pediatrics.aappublications.org/content/144/3?current-issue=y

Review Articles
Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review
Mona Marin, Jessica Leung, Anne A. Gershon
Pediatrics Sep 2019, 144 (3) e20191305; DOI: 10.1542/peds.2019-1305
We reviewed the published experience with the use of live VZV vaccines to assess characteristics of secondary transmission of the vaccine-strain virus.

PharmacoEconomics
Volume 37, Issue 9, September 2019
https://link.springer.com/journal/40273/37/9

Systematic Review
Cost Effectiveness of Elderly Pneumococcal Vaccination in Presence of Higher-Valent Pneumococcal Conjugate Childhood Vaccination: Systematic Literature Review with Focus on Methods and Assumptions
Marina Treskova, Stefan M. Scholz, Alexander Kuhlmann

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 7 Sep2019)

Collection Review
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
Christian Lienhardt, Andrew A. Vernon, Marco Cavaleri, Sumati Nambiar, Payam Nahid
| published 06 Sep 2019 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1002915

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 7 Sep2019)

Research Article
Social network interventions for health behaviours and outcomes: A systematic review and meta-analysis
There has been a growing interest in understanding the effects of social networks on health-related behaviour, with a particular backdrop being the emerging prominence of complexity or systems science in public health. Social network interventions specifically use or alter the characteristics of social networks to generate, accelerate, or maintain health behaviours. We conducted a systematic review and meta-analysis to investigate health behaviour outcomes of social network interventions.
Ruth F. Hunter, Kayla de la Haye, Jennifer M. Murray, Jennifer Badham, Thomas W. Valente, Mike Clarke, Frank Kee
| published 03 Sep 2019 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1002890

PLoS One
http://www.plosone.org/
[Accessed 7 Sep2019]

Research Article
Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda
Irene Nakatudde, Joseph Rujumba, Flavia Namiiro, Ali Sam, Jamir Mugalu, Philippa Musoke
Research Article | published 06 Sep 2019 PLOS ONE
https://doi.org/10.1371/journal.pone.0221902

PLoS One
http://www.plosone.org/
[Accessed 7 Sep2019]

Burden of influenza-associated respiratory hospitalizations in the Americas, 2010–2015
Rakhee S. Palekar, Melissa A. Rolfes, C. Sofia Arriola, Belsy O. Acosta, Patricia Alberto Guidos, Xiomara Badilla Vargas, Christina Bancej, Juliana Barbosa Ramirez, Elsa Baumeister, Alfredo Bruno, Maria Agüeda Cabello, Jufu Chen, Paula Couto, Francisco J. De Paula Junior, Rodrigo Fasce, Walquiria Ferreira de Almeida, Victor E. Fiesta Solorzano, Carlos Flores Ramírez, Natalia Goñi, Yadira Isaza de Moltó, Jenny Lara, Diana C. Malo, José L. Medina Osis, Homer Mejía, Lourdes Moreno Castillo, Desiree Mustaquim, Andrea Nwosu, Jenny Ojeda, Antonio Paredes Samoya, Paola A. Pulido, Hector M. Ramos Hernandez, Rudvelinda Rivera Lopez, Angel Rodriguez, Myriam Saboui, Hilda Salazar Bolanos, Adrián Santoro, Jose Eduardo Silvera, Paulina Sosa, Viviana Sotomayor, Lourdes Suarez, Marta Von Horoch, Eduardo Azziz-Baumgartner
Research Article | published 06 Sep 2019 PLOS ONE
https://doi.org/10.1371/journal.pone.0221479

PLoS One
http://www.plosone.org/
[Accessed 7 Sep2019]

Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016
Eva Ferreras, Belem Matapo, Elizabeth Chizema-Kawesha, Orbrie Chewe, Hannah Mzyece, Alexandre Blake, Loveness Moonde, Gideon Zulu, Marc Poncin, Nyambe Sinyange, Nancy Kasese-Chanda, Caroline Phiri, Kennedy Malama, Victor Mukonka, Sandra Cohuet, Florent Uzzeni, Iza Ciglenecki, M. Carolina Danovaro-Holliday, Francisco J. Luquero, Lorenzo Pezzoli
Research Article | published 30 Aug 2019 PLOS ONE
https://doi.org/10.1371/journal.pone.0219040
Abstract
Background
In April 2016, an emergency vaccination campaign using one dose of Oral Cholera Vaccine (OCV) was organized in response to a cholera outbreak that started in Lusaka in February 2016. In December 2016, a second round of vaccination was conducted, with the objective of increasing the duration of protection, before the high-risk period for cholera transmission. We assessed vaccination coverage for the first and second rounds of the OCV campaign.
Methods
Vaccination coverage was estimated after each round from a sample selected from targeted-areas for vaccination using a cross-sectional survey in to establish the vaccination status of the individuals recruited. The study population included all individuals older than 12 months residing in the areas targeted for vaccination. We interviewed 505 randomly selected individuals after the first round and 442 after the second round. Vaccination status was ascertained either by vaccination card or verbal reporting. Households were selected using spatial random sampling.
Results
The vaccination coverage with two doses was 58.1% (25/43; 95%CI: 42.1–72.9) in children 1–5 years old, 59.5% (69/116; 95%CI: 49.9–68.5) in children 5–15 years old and 19.9% (56/281; 95%CI: 15.4–25.1) in adults above 15 years old. The overall dropout rate was 10.9% (95%CI: 8.1–14.1). Overall, 69.9% (n = 309/442; 95%CI: 65.4–74.1) reported to have received at least one OCV dose.
Conclusions
The areas at highest risk of suffering cholera outbreaks were targeted for vaccination obtaining relatively high vaccine coverage after each round. However, the long delay between doses in areas subject to considerable population movement resulted in many individuals receiving only one OCV dose. Additional vaccination campaigns may be required to sustain protection over time in case of persistence of risk. Further evidence is needed to establish a maximum optimal interval time of a delayed second dose and variations in different settings.

Public Health Reports
Volume 134 Issue 5, September/October 2019
https://journals.sagepub.com/toc/phrg/134/5

Research
Completion of the Human Papillomavirus Vaccination Series Among Adolescent Users and Nonusers of School-Based Health Centers
Meaghan S. Munn, MPH, Meagan Kay, DVM, MPVM, Libby C. Page, MPH, Jeffrey S. Duchin, MD
First Published August 12, 2019; pp. 559–566

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
http://www.paho.org/journal/index.php?option=com_content&view=featured&Itemid=101

6 Sep 2019
Initial care for migrants in Chile: status of a primary health care initiative after one year of implementation
Original research | Spanish |

Science
06 September 2019 Vol 365, Issue 6457
http://www.sciencemag.org/current.dtl

In Depth
Controversy over dengue vaccine risk
By Jon Cohen
Science06 Sep 2019 : 961-962 Restricted Access
All immunized Filipino kids should be tested, some say.
Summary
Shortly after Dengvaxia came to market in 2015, the Philippines launched a massive campaign to immunize children against the dreaded diseases. After about 1 million children were vaccinated, Sanofi Pasteur, the Paris-based maker of the product, revealed that ongoing clinical trials had found a rare, dangerous complication. Four distinct variants of dengue infect humans. In a well-known phenomenon, people infected with one strain who become infected with a second one become vulnerable to severe dengue, which can cause life-threatening shock and hemorrhagic fever. The vaccine, when given to children who had never been infected with dengue, primes some for that rare phenomenon of severe disease. Now, some researchers are calling for studies that would test the vaccinated children and identify the ones most at risk. They contend that if parents knew their children were at increased risk of severe disease, they could more aggressively seek care if they suspected dengue. This also might alleviate confusion for some parents who have blamed the vaccine for the death of their children. But no one has sponsored the study yet.

Tropical Medicine & International Health
Volume 24, Issue 9 Pages: i-iv, 1031-1137 September 2019
https://onlinelibrary.wiley.com/toc/13653156/current

Original Research Papers
Awareness and attitude towards human papillomavirus and its vaccine among females with and without daughter(s) who participated in cervical cancer screening in Shenzhen, China
Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
Pages: 1054-1063
First Published: 02 July 2019

Vaccine
Volume 37, Issue 39 Pages 5807-5908 (16 September 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/39

Review article Abstract only
Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation
Akash Malik, Pradeep Haldar, Arindam Ray, Anita Shet, … Rakesh Kumar
Pages 5817-5824

Vaccine
Volume 37, Issue 39 Pages 5807-5908 (16 September 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/39

Review article Abstract only
Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study
Parveen Fathima, Heather F. Gidding, Thomas L. Snelling, Peter B. McIntyre, … Hannah C. Moore
Pages 5835-5843
Abstract
Objectives
Rotavirus vaccines (RV), included in Australia’s National Immunisation Program from mid-July 2007, are unique in strict time limits for administration. Here, we report on timeliness of RV uptake, compare cumulative RV coverage to age 12 months with DTPa, and assess factors associated with receipt of RV among Aboriginal and non-Aboriginal children.
Methods
Birth records for 681,456 children born in two Australian states in 2007–2012 were probabilistically linked to national immunisation records. We assessed on-time coverage (defined as receipt of vaccine dose between 4 days prior to scheduled date and the recommended upper limit) for RV and compared this to diphtheria-tetanus-pertussis (DTPa) vaccine. Logistic regression modelling was used to assess independent determinants of receipt of RV.
Results
Compared to non-Aboriginal infants, on-time RV coverage was lower for all doses among Aboriginal infants. Post the upper age limit of RV dose2, DTPa dose2 coverage increased by 9–16% to ≥90%, whereas RV coverage remained around 77% (Aboriginal) and 85% (non-Aboriginal). Compared to first-born children, the adjusted odds of receiving ≥1 RV dose if born to a mother with ≥3 previous births was 0.30 (95%CI: 0.27–0.34) among Aboriginal, and 0.53 (95%CI: 0.51–0.55) among non-Aboriginal children. Prematurity (<33 weeks), low birthweight (<1500 g), maternal age <20 years, maternal smoking during pregnancy and living in a disadvantaged area were independently associated with decreased vaccine uptake.
Conclusions
Aboriginal children are at greater risk of rotavirus disease than non-Aboriginal children and delayed vaccine receipt is substantially higher. Although specific programs targeting groups at risk of delayed vaccination might improve RV coverage, relaxation of upper age restrictions is most readily implementable, and its overall risk-benefit should be evaluated.

Vaccine
Volume 37, Issue 39 Pages 5807-5908 (16 September 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/39

Review article Abstract only
Timeliness of immunisations in preterm infants in the Netherlands
Elsbeth D.M. Rouers, Guy A.M. Berbers, Josephine A.P. van Dongen, Elisabeth A.M. Sanders, … Patricia Bruijning-Verhagen
Pages 5862-5867

Vaccine
Volume 37, Issue 39 Pages 5807-5908 (16 September 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/39

Research article Open access
Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia
Joshua Nealon, Wei-Yin Lim, Annick Moureau, Sharon Linus Lojikip, … Amar-Singh HSS
Pages 5891-5898

Vaccine
Volume 37, Issue 39 Pages 5807-5908 (16 September 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/39

Research article Open access
Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia
Joshua Nealon, Wei-Yin Lim, Annick Moureau, Sharon Linus Lojikip, … Amar-Singh HSS
Pages 5891-5898

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

Nature Immunology
Published: 02 September 2019
Comment
Vaccine hesitancy and coercion: all eyes on France
JK Ward, P Peretti-Watel, A Bocquier, V Seror, P Verger –
With record levels of vaccine hesitancy and one of the most drastic reinforcements of vaccine mandates in recent years, there is much to learn from the French experience.

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

ABC News – Australia
https://www.abc.net.au/news/
Accessed 7 Sep2019
Politics
‘No jab, no pay’ threat prompts an extra 174,000 children to be vaccinated in one year
By political reporter Matthew Doran
Posted 31 Aug 2019, 8:55pm
A threat to cut family tax benefits for Australians who did not vaccinate their children has resulted in an increase of 174,000 children being immunised over the last year.

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 7 Sep2019
[No new, unique, relevant content]

BBC
http://www.bbc.co.uk/
Accessed 7 Sep2019
[No new, unique, relevant content]

The Economist
http://www.economist.com/
Accessed 7 Sep2019
[No new, unique, relevant content]

The Express Tribune – Pakistan
https://tribune.com.pk/
Accessed 7 Sep2019
Pakistan
With no refusal cases reported 7.1m children vaccinated in fresh polio drive
Published: August 30, 201
ISLAMABAD  : Around 7.1 million children in 46 districts of the country were administered polio drops in the recent vaccination campaign, according to the government figures.
“The recent campaign was successful,” read a statement issued by the Pakistan Polio Programme.
“No news of torture or verbal altercations in any part of the country was received.”…

Financial Times
http://www.ft.com/home/uk
Accessed 7 Sep2019
[No new, unique, relevant content]

Forbes
http://www.forbes.com/
Accessed 7 Sep2019
[No new, unique, relevant content]

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 7 Sep2019
[No new, unique, relevant content]

Foreign Policy
http://foreignpolicy.com/
Accessed 7 Sep2019
[No new, unique, relevant content]

The Guardian
http://www.guardiannews.com/
Accessed 7 Sep2019
Vaccines and immunisation
Facebook to direct vaccine searches to public health pages
Facebook moves to stem spread of misinformation online about side-effects of immunisations
Sarah Boseley Health editor
Wed 4 Sep 2019 11.00 EDT
Facebook is to take a stand against vaccine denial by directing people searching for information or using vaccine hashtags to web pages set up by public health bodies.
People who access Facebook and Instagram pages and groups that discuss vaccines, as well as those searching or using relevant hashtags, will see an educational module about vaccine safety. Links will take them to a page provided by the Centers for Disease Control and Prevention (CDC) in the United States and to the World Health Organization elsewhere in the world…

New Yorker
http://www.newyorker.com/
Accessed 7 Sep2019
[No new, unique, relevant content]

New York Times
http://www.nytimes.com/
Accessed 7 Sep2019
Asia Pacific
WHO Welcomes Facebook Pledge to Curb Anti-Vaccine Misinformation
The World Health Organization said on Thursday it welcomed a commitment by Facebook that it would direct users seeking vaccine information on its Instagram, Facebook Search, Groups and other forums towards facts, not misinformation.
By Reuters

Africa
Former Congo Health Minister Questioned Over Ebola Spending
Sept. 2
Democratic Republic of Congo’s former health minister has been questioned by police over his management of funds in the country’s response to the Ebola epidemic, his lawyers said on Monday.
By Reuters

STAT
https://www.statnews.com/
Accessed 7 Sep2019
Health
With new grants, Gates Foundation takes an early step toward a universal flu vaccine
By Helen Branswell
August 29, 2019

Health
Federal rules threaten to discourage undocumented immigrants from vaccinating children
By Helen Branswell
August 26, 2019

Washington Post
http://www.washingtonpost.com/
Accessed 7 Sep2019
California lawmaker, governor reach deal on vaccine bill
Don Thompson | AP · National · Sep 6, 2019

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 7 Sep2019
[No new relevant content]

Center for Global Development
http://www.cgdev.org/page/press-center
[No new relevant content]

CSIS
https://www.csis.org/
Accessed 7 Sep2019
[No new relevant content]

Council on Foreign Relations
http://www.cfr.org/
Accessed 7 Sep2019
[No new relevant content]

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 7 Sep2019
[No new relevant content]